Mission Bio Investor
Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.
Investors
Technology:
Non-clinical Applications
Industry:
AI for Longevity
Headquarters:
San Francisco, California, United States
Founded Date:
2012-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investor Type:
For Profit
Investors Number:
12
Total Funding:
$110.1M
Estimated Revenue:
$10M to $50M
Last Funding Type:
Series C
Register and Claim Ownership